First use of icatibant (selective bradykinin receptor antagonist) in hereditary angioedema patients in the UK

被引：0
|
作者：
Karanam, S.
Demptser, J.
Longhurst, H.
Gompels, M.
机构：
[1] Southmead Hosp, Bristol, Avon, England
[2] St Bartholomews Hosp, London, England
来源：
CLINICAL AND EXPERIMENTAL ALLERGY | 2009年 / 39卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1943 / 1943
页数：1
相关论文
共 50 条
  • [41] Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study
    Campos, Regis Albuquerque
    Rodrigues Valle, Solange Oliveira
    Franca, Alfeu Tavares
    Cordeiro, Elisabete
    Serpa, Faradiba Sarquis
    Mello, Yara Ferreira
    Malheiros, Teresinha
    Toledo, Eliana
    Mansour, Elie
    Fusaro, Gustavo
    Grumach, Anete Sevciovic
    SAO PAULO MEDICAL JOURNAL, 2014, 132 (05): : 261 - 265
  • [42] Successful treatment of ACE inhibitor-induced angioedema with icatibant, a bradykinin B2 receptor antagonist
    Pucar, Phillippa A.
    O'Sullivan, Michael
    Goudie, Adrian
    Marr, Timothy
    Brusch, Anna
    MEDICAL JOURNAL OF AUSTRALIA, 2015, 202 (11) : 596 - 597
  • [43] Case series of UK experience of Icatibant for acute attacks of hereditary angioedema
    Dempster, J.
    Gompels, M.
    Bright, P.
    Longhurst, H.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 160 : 11 - 12
  • [44] First report of icatibant treatment in a pregnant patient with hereditary angioedema
    Farkas, Henriette
    Kohalmi, Kinga Viktoria
    Veszeli, Nora
    Toth, Ferenc
    Varga, Lilian
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2016, 42 (08) : 1026 - 1028
  • [45] The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema
    Maurer, Marcus
    Aberer, Werner
    Caballero, Teresa
    Bouillet, Laurence
    Grumach, Anete S.
    Botha, Jaco
    Andresen, Irmgard
    Longhurst, Hilary J.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (09): : 1048 - 1058
  • [46] BRADYKININ B2 RECEPTOR ANTAGONIST OFF LABEL USE IN SHORT-TERM PROPHYLAXIS IN HEREDITARY ANGIOEDEMA
    Angeletti, C.
    Angeletti, P. M.
    Mastrobuono, F.
    Pilotti, L.
    Ciccozzi, A.
    Guetti, C.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2014, 27 (04) : 653 - 659
  • [47] Successful treatment of 103 attacks of hereditary hngioedema (HAE) with bradykinin B2 receptor antagonist icatibant
    Malbran, A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S102 - S102
  • [48] Are hereditary angioedema patients satisfied with on-demand therapy with icatibant?
    Beyaz, Sengul
    Demir, Semra
    Oztop, Nida
    Colakoglu, Bahauddin
    Buyukozturk, Suna
    Gelincik, Asli
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 357 - 357
  • [49] Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema
    Farkas, Henriette
    Reshef, Avner
    Aberer, Werner
    Caballero, Teresa
    McCarthy, Laura
    Hao, James
    Nothaft, Wolfram
    Schranz, Jennifer
    Bernstein, Jonathan A.
    Li, H. Henry
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1671 - +
  • [50] Early Versus Late Administration of Icatibant in Patients With Hereditary Angioedema
    Zanichelli, A.
    Maurer, M.
    Aberer, W.
    Caballero, T.
    Bouillet, L.
    Bygum, A.
    Grumach, A. S.
    Botha, J.
    Andresen, I
    Longhurst, H. J.
    SWISS MEDICAL WEEKLY, 2018, 148 : 24S - 24S
12345